Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> WHO Experts Unable to Find ‘Missing Link’ in SARS-CoV2 Virus Transmission in China 09/02/2021 Kerry Cullinan & Elaine Ruth Fletcher The most likely way that the SARS-CoV2 virus spread in Wuhan was from an animal intermediary that transmitted the virus from bats to humans, while the least likely was that it resulted from a laboratory “incident”, according to the World Health Organization (WHO) team on the origin of the virus, which completed a month-long investigation […] Continue reading -> WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Experts Unable to Find ‘Missing Link’ in SARS-CoV2 Virus Transmission in China 09/02/2021 Kerry Cullinan & Elaine Ruth Fletcher The most likely way that the SARS-CoV2 virus spread in Wuhan was from an animal intermediary that transmitted the virus from bats to humans, while the least likely was that it resulted from a laboratory “incident”, according to the World Health Organization (WHO) team on the origin of the virus, which completed a month-long investigation […] Continue reading -> WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Decision on AstraZeneca COVID-19 Vaccine Expected Next Week, Chinese Vaccine Decision in Advanced Stage 05/02/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) expects to make a decision next week on whether to issue emergency use licenses for the AstraZeneca/Oxford COVID-19 vaccine being produced by the Serum Institute of India (SII) and South Korea’s SK Bioscience on 15 February, according to Dr Mariangela Simão, the organisation’s assistant director general of Drug Access, Vaccines […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Posts navigation Older Posts Newer Posts